Back to All Events

Protean BioDiagnostic's CEO to Present Webinar on Current and Emerging Biomarkers in Immuno-Oncology

Dr. Anthony Magliocco, the Protean BioDiagnostics CEO will be presenting an update webinar on current and emerging biomarkers in immuno-oncology, on September 5th.

Pathologists play a crucial role in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This webinar will empower you to understand the biology behind current and emerging immuno-oncology biomarkers.

Some of the learning objectives of the webinar are : review of the immune system and cancer, current and Emerging predictive I-O biomarkers, and biomarker testing practicalities.

Register for the webinar on the event website